Department of Vascular Surgery, Henri Mondor Hospital, AP/HP, University Paris Val de Marne, Créteil 94000, Paris, France.
Eur J Vasc Endovasc Surg. 2010 Nov;40(5):582-8. doi: 10.1016/j.ejvs.2010.07.020. Epub 2010 Sep 16.
To assess causative pathogens and surgical outcomes in patients with primary infected aorto-iliac aneurysms at our institution.
Retrospective study of patients treated at a university hospital between 1992 and 2009.
We identified 26 patients (median age, 63 years) with primary infected aneurysms on the aorta (descending thoracic, n = 2; thoraco-abdominal, n = 3; suprarenal, n = 2; infrarenal, n = 15) or iliac arteries (n = 4). Among them, 22 were symptomatic, including 13 with ruptured aneurysms. The causative organisms, identified in 25/26 patients, were Campylobacter fetus, n = 6; Streptococcus pneumoniae, n = 4; Listeria, n = 3; Salmonella, n = 2; Mycobacterium tuberculosis, n = 2; Staphylococcus aureus, n = 1; and other, n = 7. Immune suppression was a feature in 10 (38.4%) patients. Revascularisation was performed in situ in 23 patients (10 allografts, eight grafts, three superficial femoral veins, and 2 stentgrafts) and by extra-anatomic bypass in three patients. Hospital mortality was 23% (in situ group, 17.4%; extra-anatomic group, 66.7%; χ(2)(Yates), P = 0.24). During follow-up in the 20 survivors (median, 48.5 months), there were two non-infection-related deaths (five and 24 months) and six (30%) vascular complications.
The bacteriological spectrum of primary infected aorto-iliac aneurysms was wider than previously reported. The availability of new diagnostic tests and increased prevalence of immunosuppression may explain this finding.
评估本机构原发性感染性主髂动脉瘤患者的致病病原体和手术结果。
对 1992 年至 2009 年在一家大学医院治疗的患者进行回顾性研究。
我们共确定了 26 例原发性感染性主髂动脉瘤患者(中位年龄 63 岁),病变位于降胸主动脉(n=2)、胸腹主动脉(n=3)、肾上主动脉(n=2)、肾下主动脉(n=15)或髂动脉(n=4)。其中 22 例有症状,包括 13 例为破裂性动脉瘤。25/26 例患者的致病病原体被鉴定,包括胎儿弯曲菌(n=6)、肺炎链球菌(n=4)、李斯特菌(n=3)、沙门氏菌(n=2)、结核分枝杆菌(n=2)、金黄色葡萄球菌(n=1)和其他(n=7)。10 例(38.4%)患者存在免疫抑制。23 例患者行原位血管重建(10 例同种异体移植物、8 例移植物、3 例股浅静脉和 2 例支架移植物),3 例患者行体外旁路手术。院内死亡率为 23%(原位组为 17.4%;体外旁路组为 66.7%;Yates χ2 检验,P=0.24)。20 例存活患者(中位随访时间为 48.5 个月)中,有 2 例(分别在术后 5 个月和 24 个月)非感染相关死亡,6 例(30%)发生血管并发症。
原发性感染性主髂动脉瘤的细菌谱比以前报道的更广泛。新的诊断检测方法的出现和免疫抑制的普遍增加可能解释了这一发现。